Pharmaceuticals

Rising Prevalence Of Infectious Diseases Fuels Peptide Antibiotics Market Is Supporting Development Across The Peptide Antibiotics Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Peptide Antibiotics Market In 2026 And 2030?

The peptide antibiotics market has shown robust expansion over recent years. Its size is expected to increase from $5.77 billion in 2025 to $6.32 billion in 2026, at a compound annual growth rate (CAGR) of 9.6%. The market’s past growth is primarily due to the rise of antibiotic-resistant bacterial strains, higher rates of hospital-acquired infections, advancements in peptide synthesis technologies, an increase in clinical research for infectious diseases, and government funding for antibiotic research and development.

The peptide antibiotics market size is anticipated to experience robust growth in the upcoming years. It is projected to reach $9.04 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. This expansion over the forecast period can be attributed to factors such as the escalating prevalence of multi-drug resistant infections, the development of global healthcare infrastructure, technological progress in peptide delivery systems, an increase in partnerships with CDMOs, and a growing understanding and acceptance of precision medicine approaches. Key trends anticipated in the forecast period include a heightened demand for solutions targeting multi-drug resistant (MDR) infections, the broader application of peptide antibiotics in addressing hospital-acquired infections, an increase in contract manufacturing and CDMO collaborations, the rising adoption of personalized and targeted antibiotic therapies, and a focus on developing peptide antibiotics with minimized toxicity and side effects.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

What Core Drivers Are Transforming The Peptide Antibiotics Market?

The increasing occurrence of various infectious diseases is anticipated to drive the expansion of the peptide antibiotics market. Infectious diseases are conditions caused by harmful microbes such as bacteria, fungi, and parasites, among others. The primary reasons for the uptick in these illnesses include rapid urbanization, climate change, and an escalating risk of disease emergence, all of which have heightened the demand for peptide antibiotics. These antibiotics work by physically rupturing cell membranes, thus forming the basis of their antibacterial activity. For instance, in May 2024, the World Health Organization, a Switzerland-based intergovernmental organization, stated that in the America region, dengue cases had already exceeded seven million by April 2024, a figure substantially higher than the 4.6 million cases reported for the entirety of 2023. Therefore, the rising incidence of infectious diseases is fueling the growth of the peptide antibiotics market.

How Are Different Segment Groups Identified Within The Peptide Antibiotics Market?

The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics

2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases

4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:

1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides

2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

Which Trends Are Guiding The Development Of The Peptide Antibiotics Market?

Prominent companies in the peptide antibiotics market are launching generic versions to provide patients with more affordable options. These generic peptide antibiotics serve as cost-effective, off-patent alternatives to branded peptide-based antibiotics, used for treating various bacterial infections. For example, in July 2023, Camber Pharmaceuticals, a US-based pharmaceutical company, expanded its portfolio by introducing a generic version of Daptomycin for Injection. Daptomycin for Injection is a specific type of peptide antibiotic, a cyclic lipopeptide antibiotic created through non-ribosomal machinery. This generic variant is available in 350 mg and 500 mg strengths and is indicated for the management of complicated skin and skin structure infections (cSSSI) in both adult and pediatric patients aged 1 to 17 years.

Which Organizations Are Operating Within The Peptide Antibiotics Market?

Major companies operating in the peptide antibiotics market are Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Basilea Pharmaceutica Ltd.

Access The Complete Peptide Antibiotics Market Report:

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Which Region Contributes The Most To The Peptide Antibiotics Market?

North America was the largest region in the peptide antibiotics market in 2025. The regions covered in the peptide antibiotics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Peptide Antibiotics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

Browse Through More Reports Similar to the Global Peptide Antibiotics Market 2026, By The Business Research Company

Peptide Antibiotics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Antibiotics Market Report 2026

https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795